These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 6770460

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Transmission of hepatitis C by factor concentrates].
    Aguilar C, Lucía JF.
    Sangre (Barc); 1996 Apr; 41(2):160-1. PubMed ID: 9045360
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Virus in hemophilia: current status and future perspectives].
    Aguilar C, Félix Lucía J.
    Sangre (Barc); 1996 Apr; 41(2):141-5. PubMed ID: 9045355
    [No Abstract] [Full Text] [Related]

  • 9. Hepatitis C and pasteurised factor VIII and IX concentrates.
    Klarmann D, Kreuz W, Auerswald G, Auberger K, Rabenau H, Gürtler L, Roggendorf M.
    Thromb Haemost; 1995 Apr; 73(4):736-7. PubMed ID: 7495095
    [No Abstract] [Full Text] [Related]

  • 10. Acquired hemolytic anemia and thrombocytopenia (Evans' syndrome) in hemophilia.
    Harris PJ, Kessler CM, Lessin LS.
    N Engl J Med; 1983 Jul 07; 309(1):50. PubMed ID: 6406894
    [No Abstract] [Full Text] [Related]

  • 11. Hepatitis A virus sequence detected in clotting factor concentrates associated with disease transmission.
    Robertson BH, Alter MJ, Bell BP, Evatt B, McCaustland KA, Shapiro CN, Sinha SD, Souci JM.
    Biologicals; 1998 Jun 07; 26(2):95-9. PubMed ID: 9811512
    [Abstract] [Full Text] [Related]

  • 12. Hemophilia. Judge puts limit on expert testimony from drug makers.
    AIDS Policy Law; 1997 Jan 24; 12(1):5. PubMed ID: 12162262
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Therapeutic properties and safety of recombinant factor VIII and factor IX.
    Zdziarska J, Chojnowski K, Klukowska A, Łetowska M, Mital A, Podolak-Dawidziak M, Windyga J, Zawilska K, Working Group on Hemostasis of the Polish Society of Hematologists and Transfusiologists.
    Pol Arch Med Wewn; 2009 Jun 24; 119(6):403-9. PubMed ID: 19694223
    [Abstract] [Full Text] [Related]

  • 16. Products for the treatment of hemophilia A and B prepared by ion exchange chromatography.
    Sultan Y, Boyeldieu D, Stieltjes N.
    Nouv Rev Fr Hematol (1978); 1994 Jun 24; 36 Suppl 1():S59-60. PubMed ID: 8177717
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hepatitis A among persons with hemophilia who received clotting factor concentrate--United States, September-December 1995.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1996 Jan 19; 45(2):29-32. PubMed ID: 8531917
    [Abstract] [Full Text] [Related]

  • 20. A guide for home treatment--Madrid 1978.
    Scand J Haematol Suppl; 1980 Jan 19; 35():1-27. PubMed ID: 6770457
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.